Steep rise in older Britons hospitalised for drug abuse
Number of middle-aged patients suffering drug-related mental disorders has surged by 85% over the past decade
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
You are now subscribed
Your newsletter sign-up was successful
NHS hospitals have seen a massive increase in the number of middle-aged and older people being admitted for drug misuse, according to a new report by the health service.
The latest annual statistics for England reveal that admissions of people aged 45 and above for drug-related mental and behavioural disorders have almost doubled since 2007, from 638 to 1,182, compared with only a 1% increase for those aged under 45. Typical symptoms include “hallucinations, confusion, extreme agitation and disinhibition”, The Guardian reports.
Hospital admissions for poisoning as a result of drug misuse has increased by 32% over the past six years among people aged 55 and above.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
And around one in three drug-related deaths registered in 2017 were of people aged between 40 and 49, higher than any other age group.
Experts have warned that so-called baby boomers are in denial over alcohol and drug abuse, and are less likely to accept they have a problem than younger people, reports The Daily Telegraph.
The Guardian says that the figures have also “prompted experts to claim that controversial changes in the Government’s approach to drug addiction”, which now emphasises abstinence over harm reduction, has led to the rise in admissions.
“It is clear from this data that older people are suffering the consequences of cuts made to drug treatment services over recent years,” said Ian Hamilton, associate professor of addiction at the University of York.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
“They are more likely to have had longer drug-using careers, so they will need longer in specialist drug treatment. However, unfortunately, treatment services are being directed to offer abstinence-based services rather than maintaining this group on substitute drugs like methadone.”
Hamilton suggested that naloxone, a medication that can block the effect of opioids following a potentially fatal overdose, should be more readily available, along with “safe injection facilities” where users can inject drugs in a hygienic environment.
Last year there were a total of 2,503 drug-related deaths in England - a slight decrease from 2016 (2,596), but a 38% increase from 2007 (1,809).
-
5 cinematic cartoons about Bezos betting big on 'Melania'Cartoons Artists take on a girlboss, a fetching newspaper, and more
-
The fall of the generals: China’s military purgeIn the Spotlight Xi Jinping’s extraordinary removal of senior general proves that no-one is safe from anti-corruption drive that has investigated millions
-
Why the Gorton and Denton by-election is a ‘Frankenstein’s monster’Talking Point Reform and the Greens have the Labour seat in their sights, but the constituency’s complex demographics make messaging tricky
-
A real head scratcher: how scabies returned to the UKThe Explainer The ‘Victorian-era’ condition is on the rise in the UK, and experts aren’t sure why
-
A fentanyl vaccine may be on the horizonUnder the radar Taking a serious jab at the opioid epidemic
-
How dangerous is the ‘K’ strain super-flu?The Explainer Surge in cases of new variant H3N2 flu in UK and around the world
-
Nitazene is quietly increasing opioid deathsThe explainer The drug is usually consumed accidentally
-
The ‘menopause gold rush’Under the Radar Women vulnerable to misinformation and marketing of ‘unregulated’ products
-
Can TrumpRx really lower drug prices?Today’s Big Question Pfizer’s deal with Trump sent drugmaker stocks higher
-
The UK’s opioid crisis: why the stats don’t add upThe Explainer A new report has revealed that the UK’s total of opioid-related deaths could be much greater than official figures show
-
Why the FDA wants to restrict kratom-related productsIn the Spotlight The compound is currently sold across the United States